Terns Pharmaceuticals, Inc. · NASDAQ:TERN
The Vanguard Group reported a 5.21% stake in Terns Pharmaceuticals, Inc. (Schedule 13G)
Event Sep 30, 2025 · Filed Oct 31, 2025
The Vanguard Group reported a 5.21% stake in Terns Pharmaceuticals, Inc., 4,559,917 shares, as a passive investor on Sep 30, 2025. Filed Oct 31, 2025 (Schedule 13G).
- Stake
- 5.21%
- Shares
- 4,559,917
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 5.21% | 4,559,917 |
Source
Related
- Terns Pharmaceuticals, Inc.
- The Vanguard Group
- Terns Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026
- Schedule 13G/A · Morgan Stanley · Jun 5, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · May 13, 2026
- Schedule 13G/A · Morgan Stanley · May 12, 2026
- Form 4 · Kuriakose Emil · May 5, 2026
- Form 4 · Gengos Andrew · May 5, 2026